BIOPOL
Biopol Chemicals financials
- Market cap
- ₹52 Cr
- Sector
- Chemicals
Quarterly results
| Line item | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|
| Revenue | 34 | 32 | 49 |
| EBITDA | 4 | 4 | 9 |
| Net profit | 3 | 3 | 6 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −54.8% YTD
YTD: ₹105.5 on 13 Feb 2026 → ₹47.7. High ₹128 (15 May 2026), low ₹41.55 (2 Sept 2026).
Balance sheet
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Equity capital | ₹8 Cr | ₹8 Cr | ₹11 Cr |
| Reserves | ₹1 Cr | ₹6 Cr | ₹39 Cr |
| Borrowings | ₹4 Cr | ₹8 Cr | ₹8 Cr |
| Other liabilities | ₹5 Cr | ₹10 Cr | ₹11 Cr |
| Total liabilities | ₹18 Cr | ₹32 Cr | ₹70 Cr |
| Fixed assets | ₹0 Cr | ₹0 Cr | ₹14 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹17 Cr | ₹31 Cr | ₹55 Cr |
| Total assets | ₹18 Cr | ₹32 Cr | ₹70 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Mar 2026, the public added +6.97 pp while FIIs trimmed −4.60 pp. The shareholder count grew 61% to 368.
- Promoters
- 65.8%
- FIIs
- 4.7%
- DIIs
- 0.5%
- Public
- 28.9%
Since Mar 2026
- Public +6.97 pp
- FIIs −4.60 pp
- DIIs −2.38 pp
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Ankit Kumar Jain newly disclosed 2.11% held
- Singasandra Nagappa Mahadeva newly disclosed 1.45% held
The same filing shows 3 holders trimming and 3 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Biopol Chemicals Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Santanu Sarkar | 64.14% | unchanged |
| Kingsman Wealth Management Private Limited | 5.57% | −2.14 pp |
| Beacon Stone Capital Vcc - Beacon Stone I Fccb FPI fund | 2.31% | −1.02 pp |
| Ankit Kumar Jain | 2.11% | newly disclosed |
| Craft Emerging Market Fund Pcc-Citadel Capital Fund FPI fund | 1.73% | −1.71 pp |
| Vedant Sarkar | 1.67% | unchanged |
| Singasandra Nagappa Mahadeva | 1.45% | newly disclosed |
| Kewal Krishna Vij | 0.00% | unchanged |
| Anurag Vij | 0.00% | unchanged |
| Sanjiv Vij | 0.00% | unchanged |
| Sanjay Sarkar | 0.00% | unchanged |
| Adrija Sarkar | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Biopol Chemicals Limited
Guides on how to read this kind of business and the numbers that matter.